Cargando…
Identification of MMP9 as a novel key gene in mantle cell lymphoma based on bioinformatic analysis and design of cyclic peptides as MMP9 inhibitors based on molecular docking
Mantle cell lymphoma (MCL) is an aggressive disease. MCL is associated with poor patient prognosis and limited survival. To identify key genes and explore targeting cyclic peptide inhibitors for the treatment of MCL, we downloaded two gene expression profiles (GSE32018 and GSE9327) from the Gene Exp...
Autores principales: | Yan, Wei, Li, Shawn Xiang, Wei, Minjie, Gao, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151885/ https://www.ncbi.nlm.nih.gov/pubmed/30226602 http://dx.doi.org/10.3892/or.2018.6682 |
Ejemplares similares
-
The Role of MMP-9 and MMP-9 Inhibition in Different Types of Thyroid Carcinoma
por: Li, Zhenshengnan, et al.
Publicado: (2023) -
Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas
por: Meneses-García, Abelardo, et al.
Publicado: (2008) -
Synthesis, antiinflammatory activity, and molecular docking studies of bisphosphonic esters as potential MMP-8 and MMP-9 inhibitors
por: Cortes-Pacheco, Abimelek, et al.
Publicado: (2020) -
Immunoexpression of MMP-8 and MMP-9 in chronic subdural hematoma
por: Su, Gao-Jian, et al.
Publicado: (2022) -
MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma
por: Falzone, Luca, et al.
Publicado: (2016)